Literature DB >> 7090603

[Metastases of the central nervous system: a prospective study. 3rd Communication: metastases in the pituitary gland, pineal gland, and choroid plexus (author's transl)].

D Schreiber, K Bernstein, J Schneider.   

Abstract

The following frequency of metastases was found among 737 systematically investigated malignant tumors: pituitary gland--26 cases (3.5%); choroid plexus--19 cases (2.6%); pineal gland--13 cases (1.8%). Most of the metastases were only demonstrated by histological examination. Half of the cases with secondary deposits in the pituitary gland (13/26) were single metastases without any other settlements in the central nervous system, whereas about a quarter (3/13) of the pineal metastases were single deposits. Contrary to this, the choroid plexus displayed multiply metastases including carcinosis of the brain and leptomeninges, with the exception of one case (table 5). The age distribution revealed a peak in the old age (6th to 8th decade). Males (n = 35) were more frequently affected than females (n = 23). Carcinomas of the breast, however, showed the highest tendency of all tumors for secondary spread to pituitary gland (12,5%, table 4).

Entities:  

Mesh:

Year:  1982        PMID: 7090603

Source DB:  PubMed          Journal:  Zentralbl Allg Pathol        ISSN: 0044-4030


  3 in total

Review 1.  Solitary metastasis to the choroid plexus of the lateral ventricle. Report of three cases and a review of the literature.

Authors:  M Kohno; M Matsutani; T Sasaki; K Takakura
Journal:  J Neurooncol       Date:  1996-01       Impact factor: 4.130

2.  Pineal gland metastases from mammary carcinoma.

Authors:  Norbert A Kerenyi; Elizabeth Pandula; George M Feuer
Journal:  Endocr Pathol       Date:  1994-03       Impact factor: 3.943

Review 3.  Long survival in an untreated solitary choroid plexus metastasis from renal cell carcinoma: case report and review of the literature.

Authors:  Liverana Lauretti; Eduardo Fernandez; Roberto Pallini; Luca Massimi; Alessio Albanese; Luca Denaro; Giulio Maira
Journal:  J Neurooncol       Date:  2005-01       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.